Medical
Pharmaceutical
Health

Therapix Biosciences

$2.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.80 (-24.24%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell TRPX and other stocks, options, ETFs, and crypto commission-free!

About

Therapix Biosciences Ltd. American Depositary Shares, also called Therapix Biosciences, is a specialty clinical-stage pharmaceutical company, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. Read More It initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. The company was founded on August 23, 2004 and is headquartered in Givatayim, Israel.

Employees
Headquarters
Givatayim, Tel Aviv
Founded
2004
Market Cap
8.74M
Price-Earnings Ratio
Dividend Yield
Average Volume
116.52K
High Today
$3.28
Low Today
$2.41
Open Price
$3.28
Volume
58.41K
52 Week High
$9.30
52 Week Low
$2.41

Collections

Medical
Pharmaceutical
Health
Biotechnology
Technology
2017 IPO
US
North America

Earnings

-$0.59
-$0.49
-$0.40
-$0.30
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
Actual
Expected May 30, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.